8t49: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: '''Unreleased structure''' The entry 8t49 is ON HOLD Authors: Ozorowski, G., Torres, J.L., Ward, A.B. Description: MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab [[C...
 
OCA (talk | contribs)
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Unreleased structure'''


The entry 8t49 is ON HOLD
==MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab==
<StructureSection load='8t49' size='340' side='right'caption='[[8t49]], [[Resolution|resolution]] 3.20&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[8t49]] is a 18 chain structure with sequence from [https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] and [https://en.wikipedia.org/wiki/Macaca_mulatta Macaca mulatta]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8T49 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8T49 FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8t49 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8t49 OCA], [https://pdbe.org/8t49 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8t49 RCSB], [https://www.ebi.ac.uk/pdbsum/8t49 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8t49 ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.


Authors: Ozorowski, G., Torres, J.L., Ward, A.B.
,  PMID:38753769<ref>PMID:38753769</ref>


Description: MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
[[Category: Unreleased Structures]]
</div>
[[Category: Ward, A.B]]
<div class="pdbe-citations 8t49" style="background-color:#fffaf0;"></div>
[[Category: Ozorowski, G]]
== References ==
[[Category: Torres, J.L]]
<references/>
__TOC__
</StructureSection>
[[Category: Human immunodeficiency virus 1]]
[[Category: Large Structures]]
[[Category: Macaca mulatta]]
[[Category: Ozorowski G]]
[[Category: Torres JL]]
[[Category: Ward AB]]

Latest revision as of 09:09, 4 June 2025

MD65 N332-GT5 SOSIP in complex with RM_N332_03 Fab and RM20A3 Fab

8t49, resolution 3.20Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA